For the year ending 2025-12-31, ISCO made $9,100K in revenue. -$418K in net income. Net profit margin of -4.59%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Product sales | 9,100 | 9,085 | ||
| Cost of sales | 4,033 | 3,764 | ||
| General and administrative | 3,532 | 3,516 | ||
| Selling and marketing | 1,118 | 1,216 | ||
| Research and development | 684 | 657 | ||
| Total operating expenses | 9,367 | 9,153 | ||
| Loss from operations | -267 | -68 | ||
| Other income, net | - | 4 | ||
| Interest expense | 6 | 145 | ||
| Interest expense - related party | 145 | - | ||
| Other expense, net | -151 | -141 | ||
| Net loss | -418 | -209 | ||
| Basic EPS | -0.05 | -0.03 | ||
| Diluted EPS | -0.05 | -0.03 | ||
| Basic Average Shares | 8,004,389 | 8,004,389 | ||
| Diluted Average Shares | 8,004,389 | 8,004,389 | ||
International Stem Cell CORP (ISCO)
International Stem Cell CORP (ISCO)